This information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have concerns about vitamin levels, supplements, or symptoms, please speak with your NET clinical team. They can assess your individual situation and guide you safely.
What Vitamin B3 Is
Vitamin B3 — also known as niacin, nicotinamide, or nicotinic acid — is an essential water‑soluble vitamin your body uses to convert food into energy. It supports healthy skin, nerves, digestion, and plays a central role in cellular repair and NAD⁺ production, which keeps cells functioning normally.
There are two main forms:
- Nicotinic acid – affects blood vessels and cholesterol
- Nicotinamide (niacinamide) – used in most supplements; does not cause flushing
Both ultimately support the same vitamin functions.
Why Vitamin B3 Matters
Vitamin B3 is required to make NAD⁺, a molecule involved in:
- Energy production
- DNA repair
- Cellular resilience
- Detoxification pathways
Low levels can contribute to:
- Fatigue
- Skin irritation
- Digestive discomfort
- Cognitive fog
Severe deficiency leads to pellagra, though this is rare in NETs today.
How the Body Gets Vitamin B3
You obtain B3 from:
- Food (meat, fish, eggs, nuts, seeds, whole grains)
- Conversion from tryptophan, an amino acid
- Supplements, when needed
Because the body stores very little, regular intake is important.
Vitamin B3 and Neuroendocrine Tumours (NETs)
Most NET patients maintain normal Vitamin B3 levels. However, certain NET‑related factors increase the risk of deficiency.
1. Carcinoid Syndrome and Tryptophan Diversion
This mechanism is important — but clinically significant B3 deficiency is now far less common than it used to be.
Top Bullet:
Serotonin secreting NETs (carcinoid syndrome) divert tryptophan into serotonin production, leaving too little available for the body to make Vitamin B3 (niacin).
Why this matters
- Tryptophan is the raw material the body uses to make niacin
- Serotonin‑producing NETs can consume large amounts of tryptophan
- Even with a good diet, the body may not have enough left to produce niacin
- This creates a functional B3 deficiency, independent of diet
Why it’s less common today
Modern NET care has dramatically reduced the frequency of severe tryptophan diversion:
- Somatostatin analogues (SSAs) suppress serotonin production, reducing tryptophan consumption
- Earlier diagnosis means fewer patients reach extreme serotonin‑overproduction states
- Better diarrhoea control reduces nutrient loss
- Improved nutritional support catches issues earlier
Who is most at risk today?
- Patients with active, uncontrolled carcinoid syndrome
- Those with very high serotonin output
- Patients with significant diarrhoea or malabsorption
- Individuals with extensive small bowel disease or resections
For most patients on stable treatment, Vitamin B3 deficiency is uncommon, but the mechanism remains important to understand.
2. Somatostatin Analogues (SSAs)
Medications like octreotide and lanreotide can reduce absorption of several nutrients. B3 deficiency is less common than B12 or fat‑soluble vitamin issues, but still possible due to:
- Reduced digestive enzyme activity
- Reduced mucosal absorption
- Faster or slower transit depending on the patient
3. Digestive Surgery or Malabsorption
Small bowel resections, rapid transit, or chronic diarrhoea can reduce absorption of:
- Tryptophan
- Niacin itself
Because water‑soluble vitamins are not stored, even mild malabsorption can lead to deficiency over time.
Symptoms of Low Vitamin B3
Symptoms can be subtle and overlap with other conditions:
- Persistent fatigue
- Headaches
- Irritability or low mood
- Dry or inflamed skin
- Diarrhoea
- Poor appetite
- Difficulty concentrating
More significant deficiency may cause:
- Sun‑sensitive skin rashes
- Mouth soreness
- Severe diarrhoea
- Cognitive changes
Any of these warrant clinical review.
Testing Vitamin B3 Levels
There is no single routine blood test for niacin status. Clinicians may assess:
- Symptoms
- Dietary intake
- Tryptophan metabolism markers
- NAD/NADP ratios (specialist labs only)
Testing is guided by risk factors and clinical presentation.
Supplementation
Supplementation should be guided by your clinical team.
Key points:
- Nicotinamide is usually preferred for general supplementation
- Nicotinic acid can cause flushing and is mainly used for cholesterol
- High‑dose niacin can affect the liver, blood sugar, and uric acid
- Never start high‑dose niacin without medical supervision
Most people meet their needs through diet unless they have risk factors.
Food Sources of Vitamin B3
Excellent sources include:
- Chicken, turkey
- Tuna, salmon
- Beef, pork
- Peanuts, sunflower seeds
- Whole grains
- Mushrooms
- Fortified cereals
A balanced diet typically provides sufficient amounts.
When to Speak to Your Clinical Team
Contact your NET team if you experience:
- New or worsening fatigue
- Persistent diarrhoea
- Skin changes
- Cognitive fog
- Poor appetite
- Concerns about malabsorption or carcinoid syndrome
They can assess whether Vitamin B3 deficiency is contributing.
Key Takeaways
- Vitamin B3 is essential for energy, DNA repair, and cell health.
- Carcinoid syndrome can cause deficiency by diverting tryptophan into serotonin, but this is less common today due to modern treatments.
- Malabsorption and SSAs can also contribute.
- Symptoms are non‑specific, so clinical assessment is important.
- Supplementation should be supervised.
- A varied diet usually provides adequate B3.
- NET‑Specific Evidence: The NET‑related mechanisms described in this Spotlight (pancreatic insufficiency, bile acid loss, somatostatin analogue effects, steatorrhoea, and liver involvement) are supported by the 2025 ESMO review on nutritional and micronutrient considerations in neuroendocrine neoplasms. ESMO’s observations show that patients with NETs frequently have fat-soluble vitamins (ADEK) deficiencies and deficiencies of vitamin B3 and B12 that can be successfully supplemented. As long-term deficiencies in fat-soluble vitamins and vitamins B12 and B3 can cause severe symptoms, repetitive evaluation of the status of vitamins A, D, E, K, B3, and B12 and supplementation of deficiencies is recommended in patients with NETs. Citation at Reference 3 below.
References Used
- NHS Vitamin B3 Guidance
- NIH Office of Dietary Supplements – Vitamin B3 Fact Sheet
- ESMO – Reducing deficiencies of fat-soluble vitamins, vitamin B12, and vitamin B3 in patients with neuroendocrine tumors treated with somatostatin analogues – L.D. de Hosson, S. Bunskoek, J. Stelwagen, B. Sijtema, S. Huitema, M. van Faassen, G.H. de Bock, D.J.A. de Groot, M.J.E. Campmans-Kuijpers, I.P. Kema, E.G.E. de Vries, A.M.E. Walenkamp, Volume 4, 2025, 100032, ISSN 3050-4619, https://doi.org/10.1016/j.esmorc.2025.100032. (https://www.sciencedirect.com/science/article/pii/S3050461925000310)
Thanks for reading
Thanks for reading
See also Vitamin B12 – click here
See also Vitamin B9 – click here
See the fat soluble vitamin series below
Vitamin A – click here
Vitamin D – click here
Vitamin E – click here
Vitamin K – click here
Ronny
Disclaimer
I am not a doctor or any form of medical professional, practitioner or counsellor. None of the information on my website, or linked to my website(s), or conveyed by me on any social media or presentation, should be interpreted as medical advice given or advised by me.
Neither should any post or comment made by a follower or member of my private group be assumed to be medical advice, even if that person is a healthcare professional.
Please also note that mention of a clinical service, trial/study or therapy does not constitute an endorsement of that service, trial/study or therapy by Ronny Allan, the information is provided for education and awareness purposes and/or related to Ronny Allan’s own patient experience. This element of the disclaimer includes any complementary medicine, non-prescription over the counter drugs and supplements such as vitamins and minerals.
Click here and answer all questions to join my private Facebook group
Thanks for reading.
Ronny
Check out my WEGO Health Awards
Check out my Glossary of Terms – click here
Please Share this post for Neuroendocrine Cancer awareness and to help another patient
- Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin B9 (Folate)
Before you read thisThis information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have concerns… Read more: Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin B9 (Folate) - Neuroendocrine Tumours – A Spotlight on Vitamin E (Tocopherols & Tocotrienols)
🟧A general‑population overview with NET‑specific considerations where relevant. Disclaimer: This Spotlight provides general educational information about Vitamin E. It is not a substitute for medical advice. Individual needs vary, particularly for those with conditions affecting digestion or absorption. Always consult your medical team before making changes to supplements or nutrition. What is Vitamin E? Vitamin… Read more: Neuroendocrine Tumours – A Spotlight on Vitamin E (Tocopherols & Tocotrienols) - Neuroendocrine Tumours – A Spotlight on Vitamin A (Retinol)
Disclaimer: This Spotlight provides general educational information about Vitamin A. It is not a substitute for medical advice. Individual needs vary, particularly for those with conditions affecting digestion, absorption, or liver function. Always consult your medical team before making changes to supplements or nutrition. 🟧A general‑population overview with NET‑specific considerations where relevant. What is Vitamin… Read more: Neuroendocrine Tumours – A Spotlight on Vitamin A (Retinol) - 200 Lanreotide Injections: A Milestone in Long‑Term Neuroendocrine Tumour (NET) Management
Disclaimer: Educational and advocacy content only. Not a substitute for medical advice. Two hundred injections. It’s a milestone that carries weight — not because of the number itself, but because of what it represents: continuity, stability, and the lived reality of managing Neuroendocrine Cancer over the long term. Lanreotide has been part of my life… Read more: 200 Lanreotide Injections: A Milestone in Long‑Term Neuroendocrine Tumour (NET) Management - Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin K (Phylloquinone / Menaquinones)
Before you read thisThis information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have concerns… Read more: Neuroendocrine Tumours (NETs) – A Spotlight on Vitamin K (Phylloquinone / Menaquinones) - A spotlight on Colon Neuroendocrine Neoplasms
Disclaimer: This Spotlight is for general information only and should not be used as a substitute for personalised medical advice. Neuroendocrine neoplasms (NENs) are diverse, and individual cases vary. Always discuss your specific situation, test results, and treatment options with your own specialist team. Content reflects current evidence and classifications at the time of writing… Read more: A spotlight on Colon Neuroendocrine Neoplasms - Spotlight on Thymic Neuroendocrine Neoplasms (Thymic NENs)
Disclaimer:The information in this Spotlight is for general education and awareness. It does not replace personalised medical advice, diagnosis, or treatment. Thymic Neuroendocrine Neoplasms (NENs) are complex and highly variable, and individual cases may differ significantly from the patterns described here. Always discuss your own situation, test results, and treatment options with your specialist team,… Read more: Spotlight on Thymic Neuroendocrine Neoplasms (Thymic NENs) - An unmissable update from Ronny Allan covering April 2026
A monthly update not to miss……..Summary of April 2026 on RonnyAllan.NET I think the main story of April is similar to March which was a strong blog performance. Some of March was so popular that it has rolled into April and I have tried to beat those figures but failed due to external pressures. Nonetheless, the… Read more: An unmissable update from Ronny Allan covering April 2026 - Spotlight on Small intestine Neuroendocrine Neoplasms (siNENs)
DisclaimerThis Spotlight is for general education and reassurance only. It cannot replace personalised advice from your own medical team, who understand your individual history, imaging, pathology, and treatment needs. Neuroendocrine tumours vary widely in behaviour, presentation, and management, and guidance may evolve as new evidence emerges. If you have questions about your diagnosis, symptoms, or… Read more: Spotlight on Small intestine Neuroendocrine Neoplasms (siNENs) - A Spotlight on Pancreatic Neuroendocrine Neoplasms
DisclaimerThe information in this Spotlight is for general education only. It cannot replace advice from your own medical team, who know your individual situation, test results, and treatment options. Neuroendocrine Neoplasms and related conditions are complex and research is evolving; guidance, classifications, and statistics may change over time. Always discuss any questions or concerns with… Read more: A Spotlight on Pancreatic Neuroendocrine Neoplasms - Neuroendocrine Cancer in UK – a growing crisis?
I was delighted to read about the efforts of Dr Arthur Scott, a Member of the UK Parliament (MP). He is a great advocate for cancer patients and recently introduced a rare cancer bill in the UK Parliament which will hopefully make a difference. The content was very interesting and I was drawn to several… Read more: Neuroendocrine Cancer in UK – a growing crisis? - Bone Metastases in Well‑Differentiated NETs – Part 2 – Treatment
DisclaimerThis information is for education and reassurance only.It is not a substitute for personalised medical advice, diagnosis, or treatment. Bone metastases in neuroendocrine tumours (NETs) vary widely in behaviour, appearance, and clinical significance. Decisions about systemic therapy, radiotherapy, ablation, bone‑targeted agents, surgery, or monitoring must be made by your own specialist NET team, who understand… Read more: Bone Metastases in Well‑Differentiated NETs – Part 2 – Treatment - Neuroendocrine Tumours – Vitamin B3 (Niacin)
Before you read thisThis information is designed to help you understand how vitamins work in the body and how certain NET-related factors might affect them. It is not a substitute for personalised medical advice. Every NET patient is different — tumour type, treatments, surgery, symptoms, and nutritional needs can vary widely. If you have concerns… Read more: Neuroendocrine Tumours – Vitamin B3 (Niacin) - March 2026 Newsletter from Ronny Allan
Here is my monthly summary of March 2026 on RonnyAllan.NET This has been a very good month but to be honest, I had more time at home and on my computer, due to illness. OK I was not that ill that I could not tap away at a keyboard! However, it was pretty erratic access. I… Read more: March 2026 Newsletter from Ronny Allan - Understanding Differentiation, Ki‑67, Mitotic Count, Hotspots, Pathology Workflow, and Primary–Metastasis Heterogeneity in Neuroendocrine Neoplasms (NENs)
Before you read this… This article discusses pathology concepts such as Ki-67, grading, heterogeneity, and biopsy findings in neuroendocrine tumours (NETs). It is provided for educational purposes only and does not interpret any individual pathology report or scan result. Ki-67 values, tumour grade, and sampling limitations can vary between different biopsies and over time. Their… Read more: Understanding Differentiation, Ki‑67, Mitotic Count, Hotspots, Pathology Workflow, and Primary–Metastasis Heterogeneity in Neuroendocrine Neoplasms (NENs) - Why liver transplant is back in the NET conversation
Before you read this… This article is provided to support understanding of a complex and evolving topic. It explains how liver transplant is being explored in a very small number of NET patients, but it is not suggesting that this treatment is suitable for you or anyone else. Every NET case is unique. Only your… Read more: Why liver transplant is back in the NET conversation
Discover more from Ronny Allan - Living with Neuroendocrine Cancer
Subscribe to get the latest posts sent to your email.


